1106 related articles for article (PubMed ID: 19076132)
21. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
Burri RJ; Stone NN; Unger P; Stock RG
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1338-44. PubMed ID: 20138442
[TBL] [Abstract][Full Text] [Related]
22. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Heidenreich A; Richter S; Thüer D; Pfister D
Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
[TBL] [Abstract][Full Text] [Related]
23. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
24. Robotic radical prostatectomy: outcomes of 500 cases.
Patel VR; Thaly R; Shah K
BJU Int; 2007 May; 99(5):1109-12. PubMed ID: 17437441
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
[TBL] [Abstract][Full Text] [Related]
26. Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes.
Chauhan S; Patel MB; Coelho R; Liss M; Rocco B; Sivaraman AK; Palmer KJ; Coughlin GD; Ferrigni RG; Castle EP; Ahlering TE; Parra-Davila E; Patel VR
J Endourol; 2011 Jun; 25(6):1013-9. PubMed ID: 21568696
[TBL] [Abstract][Full Text] [Related]
27. Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
Terai A; Matsui Y; Yoshimura K; Arai Y; Dodo Y
BJU Int; 2005 Nov; 96(7):1009-13. PubMed ID: 16225518
[TBL] [Abstract][Full Text] [Related]
28. Management of biochemical failure following radical prostatectomy: salvage radiotherapy - a case series.
Stockdale AD; Vakkalanka BK; Fahmy A; Desai K; Blacklock AR
Prostate Cancer Prostatic Dis; 2007; 10(2):205-9. PubMed ID: 17310262
[TBL] [Abstract][Full Text] [Related]
29. Initial results of salvage laparoscopic radical prostatectomy after radiation failure.
Vallancien G; Gupta R; Cathelineau X; Baumert H; Rozet F
J Urol; 2003 Nov; 170(5):1838-40. PubMed ID: 14532787
[TBL] [Abstract][Full Text] [Related]
30. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
[TBL] [Abstract][Full Text] [Related]
31. Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery.
Choo R; Morton G; Danjoux C; Hong E; Szumacher E; DeBoer G
Radiother Oncol; 2005 Feb; 74(2):163-7. PubMed ID: 15734204
[TBL] [Abstract][Full Text] [Related]
32. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
King CR; Presti JC; Brooks JD; Gill H; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1472-7. PubMed ID: 17935902
[TBL] [Abstract][Full Text] [Related]
33. Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients.
Kaul S; Savera A; Badani K; Fumo M; Bhandari A; Menon M
BJU Int; 2006 Mar; 97(3):467-72. PubMed ID: 16469009
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
35. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
[TBL] [Abstract][Full Text] [Related]
36. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy.
Patel R; Lepor H; Thiel RP; Taneja SS
Urology; 2005 May; 65(5):942-6. PubMed ID: 15882728
[TBL] [Abstract][Full Text] [Related]
38. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
Winter A; Uphoff J; Henke RP; Wawroschek F
Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582
[TBL] [Abstract][Full Text] [Related]
39. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.
Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw DA; Cheung P; Pearse M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):983-9. PubMed ID: 19409726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
